ArcScan develops the Insight® 100, a very‑high‑frequency (50 MHz) ultrasound imaging system that produces micron‑level, high‑resolution images of the entire anterior segment, including areas behind the iris. The system uses Swept Beam Liquid Interface™ technology and a mechanically controlled transducer to scan the eye in an arc motion, and the platform includes the device, Insight software, a fluidics module, electronics unit, and EyeSeal disposables. ArcScan's technology was originally developed and patented at Columbia/Weill University and is positioned to provide accurate biometry for pre‑ and post‑operative IOL, premium IOL, and ICL cases. The company emphasizes improved clinical outcomes by enabling accurate lens position, tilt, and volume measurements to reduce lens exchanges. ArcScan intends to leverage strategic partnerships to expand its market presence, particularly in large ophthalmology markets. The company is headquartered in Golden, Colorado.

Total raised

$11M

Funding rounds

1

Latest round

Series B

Latest activity

Jul 2021